Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Synthetic Bio Company Starts Up, Raises $53 Million

A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round. . . . → Read More: Synthetic Bio Company Starts Up, Raises $53 Million

Gut-Brain Therapies Biotech Raises $66M in New Funds

A 2 year-old biotechnology enterprise discovering new treatments for disease that harness signals between the gut and brain is raising $66 million its second venture financing round. . . . → Read More: Gut-Brain Therapies Biotech Raises $66M in New Funds

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

T-Cell Therapy Company Gains $100M in Venture Funds

A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round. . . . → Read More: T-Cell Therapy Company Gains $100M in Venture Funds

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds

Cell Engineering Company Launches, Raises $4.7 Million

A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts. . . . → Read More: Cell Engineering Company Launches, Raises $4.7 Million

Cell Programming Company Raises $49.5M in Early Funds

A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round. . . . → Read More: Cell Programming Company Raises $49.5M in Early Funds

New Finance, Development Model for Pancreatic Disease

An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis. . . . → Read More: New Finance, Development Model for Pancreatic Disease

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds